Why Pfizer Is a Much Better Stock Than You Might Think
I can sum up 's (NYSE: PFE) stock performance over the last couple of years in one word (and only three letters): ugh. Shares of the big drugmaker have plunged more than 50% since the high set in late 2022.
Pfizer's revenue and earnings are sinking like a brick. Big hurdles for the company lie ahead. All in all, this big pharma stock might look like one that investors won't want to touch with a 10-foot pole.
However, I'm actually bullish about Pfizer over the long term. Here's why it's a much better stock than you might think.
Source Fool.com
Pfizer Inc. Aktie
27,64 €
-2,73 %
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.64 € bedeuten.
